Description:

The ticker 6016.T refers to Shionogi & Co., Ltd., a prominent pharmaceutical company listed on the Tokyo Stock Exchange (TSE). Shionogi is renowned for its research and development in innovative medicines, particularly in the areas of infectious diseases, pain management, and oncology. The company has a strong global presence and is committed to improving public health through its cutting-edge drug discoveries and clinical advancements. Investors interested in the biopharmaceutical sector often keep an eye on Shionogi due to its potential for growth and contributions to medical science.

Data:

Yields: